Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001212042 | SCV001383615 | pathogenic | Long QT syndrome | 2022-07-25 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 8289). This missense change has been observed in individuals with clinical features of autosomal dominant CAV3-related conditions (PMID: 15564037, 15580566, 27061274; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 33 of the CAV3 protein (p.Asn33Lys). |
OMIM | RCV000008786 | SCV000028996 | pathogenic | Distal myopathy, Tateyama type | 2005-01-01 | no assertion criteria provided | literature only | |
Leiden Muscular Dystrophy |
RCV000008786 | SCV000045708 | not provided | Distal myopathy, Tateyama type | 2012-04-15 | no assertion provided | curation |